Terms: = Head and neck cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534 AND Prognosis
3 results:
1. Viral infections and the efficacy of PD-(L)1 inhibitors in virus-related cancers: head and neck squamous cell carcinoma and hepatocellular carcinoma.
Liu T; Li Q; Lin Z; Wang P; Chen Y; Fu Y; Ding Z
Int Immunopharmacol; 2021 Nov; 100():108128. PubMed ID: 34537483
[TBL] [Abstract] [Full Text] [Related]
2. The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer, SNAI1, in head and neck carcinoma.
Zhao H; Ling J; Huang Y; Chang A; Zhuo X
J Oral Pathol Med; 2021 Feb; 50(2):145-154. PubMed ID: 32945534
[TBL] [Abstract] [Full Text] [Related]
3. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract] [Full Text] [Related]
